Should Investors Buy or Sell Inovio Pharmaceuticals Right Now?
As COVID-19 outbreaks continue to spread around the world, biotech stocks working on possible treatments have become all the rage. Inovio Pharmaceuticals (NASDAQ: INO) has been one of the hottest biotech stocks on the market, with shares continuing to see dramatic price swings in both directions as the COVID-19 pandemic continues to spread.
Although there's a lot of excitement surrounding this company, Inovio has its fair share of critics, including one of the most well-known short-seller outfits, Citron Research. What does this mean for investors? Is now a good time to buy into this hot biotech, or should you put your money somewhere else?
Image source: Getty IMages.
Source Fool.com
